New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonists.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2007-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2007.09.089PMID 17942307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabinoids and Multiple Sclerosis

  2007cited by this paper
• Peripheral cannabinoid receptor, CB2, regulates bone mass.

  2006cited by this paper
• Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists.

  2006cited by this paper
• Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis.

  2006cited by this paper
• AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.

  2006cited by this paper
• Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

  2005cited by this paper
• Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.

  2005cited by this paper
• Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

  2005cited by this paper
• CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  2005cited by this paper
• Synthesis and biological evaluation of 1,8-naphthyridin-4(1H)-on-3-carboxamide derivatives as new ligands of cannabinoid receptors.

  2004cited by this paper
• Cannabinoid signaling in glial cells

  2004cited by this paper
• CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

  2003cited by this paper
• Cannabinoids and multiple sclerosis.

  2002cited by this paper
• Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

  2002cited by this paper
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

  2001cited by this paper
• In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.

  2001cited by this paper
• The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2).

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain.

  1997cited by this paper
• A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen.

  1985cited by this paper
• Design, synthesis, and correlation analysis of 7-substituted 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cellular respiration.

  1977cited by this paper
• Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.

  1975cited by this paper

• Medicinal Chemistry Perspective of 1,8‐Naphthyridines as Anticancer Agents

  2025cites this paper
• Natural and Synthetic Decahydroquinolines: Synthesis Strategies and Biological Activity

  2025cites this paper
• Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands

  2025cites this paper
• Development of Carborane-Based Benzothiazole Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands

  2025cites this paper
• An efficient and environmentally benign domino protocol for the synthesis of spirodihydropyridines using europium-doped ZnO nanoparticles as recyclable and reusable heterogeneous catalyst

  2025cites this paper
• Highly Selective Drug-Derived Fluorescent Probes for the Cannabinoid Receptor Type 1 (CB1R)

  2024cites this paper
• Efficient Synthesis of 8-Fluoro-10-methyl-3,4-dihydrobenzo[b][1,6]naphthyridine-2(1H)-carboxamides and Their Cytotoxic Activity

  2024cites this paper
• Eaton's reagent is an alternative of PPA: Solvent free synthesis, molecular docking and ADME studies of new angular and linear carbazole based naphtho naphthyridines

  2023cites this paper
• Quinoline: Synthesis to Application.

  2022cites this paper
• A quantitative study of the structure-activity relationship and molecular docking of 5.6.7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents using quantum chemical descriptors and statistical methods

  2022cites this paper
• Recent Advances in Synthesis and Biological Assessment of Quinoline‐Oxygen Heterocycle Hybrids

  2021cites this paper
• Synthesis of Novel Quinoline–Benzoxazolinone Ester Hybrids: In Vitro Anti-Inflammatory Activity and Antibacterial Activity

  2021cites this paper
• Synthesis of novel benzo naphtho naphthyridines from 2,4‐dicloroquinolines

  2021cites this paper
• Tetrazoloquinoline-1,2,3-Triazole Derivatives as Antimicrobial Agents: Synthesis, Biological Evaluation and Molecular Docking Study

  2020cites this paper
• A comprehensive review on the biological interest of quinoline and its derivatives.

  2020cites this paper
• 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 exerts immune-modulatory effects with good intestinal and blood brain barrier permeability

  2019cites this paper
• 7-Chloroquinoline-1,2,3-triazoyl carboxamides induce cell cycle arrest and apoptosis in human bladder carcinoma cells

  2019cites this paper
• Recent Progress in the Synthesis of Quinolines.

  2019cites this paper
• Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's disease and Less Well-Known Diseases.

  2018cites this paper
• Quinoline Heterocycles: Synthesis and Bioactivity

  2018cites this paper
• New 2-(aryl/heteroaryl)-6-(morpholin-4-yl/pyrrolidin-1-yl)-(4-trifluoromethyl)quinolines: synthesis via Buchwald–Hartwig amination, photophysics, and biomolecular binding properties

  2018cites this paper
• Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells

  2018cites this paper
• Chemistry of Cannabinoid Receptor Agonists

  2017cites this paper
• 1,8‐Naphthyridinecarbaldehydes and Their Methyl‐Substituted Precursors: Synthesis, Molecular Structures, Supramolecular Motifs and Trapped Water Clusters

  2017cites this paper
• Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.

  2017cites this paper
• Facile one‐pot synthesis of a series of 7‐aryl‐8H‐benzo[h]indeno[1,2‐b]quinoline‐8‐one derivatives catalyzed by cellulose‐based magnetic nanocomposite

  2017cites this paper
• Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.

  2017cites this paper
• Copper-catalyzed rapid C–H nitration of 8-aminoquinolines by using sodium nitrite as the nitro source under mild conditions

  2016cites this paper
• Synthesis and Cytotoxic Distinction of Benzo[h]naphtho[1,2-b][1,6] Naphthyridine and its Isomeric Benzo[b]naphtho[1,2-h][1,6]Naphthyridines

  2016cites this paper
• Synthesis, Characterizations, and Biological Effects Study of Some Quinoline Family

  2016cites this paper
• Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis.

  2016cites this paper
• Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists.

  2016cites this paper
• Synthesis and characterization of 3-aminoquinoline derivatives and studies of photophysicochemical behaviour and antimicrobial activities

  2016cites this paper
• Quantum chemical and spectroscopic investigations of 4-Hydroxy-7-methyl-1,8-naphthyridine-3-carboxylic acid

  2016cites this paper
• 1,8‐Naphthyridine Derivatives: A Review of Multiple Biological Activities

  2015cites this paper
• Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.

  2015cites this paper
• Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

  2015cites this paper
• S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission

  2015cites this paper
• New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.

  2015cites this paper
• Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor.

  2014cites this paper
• 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.

  2014cites this paper
• Organocatalytic synthesis and evaluation of 7-chloroquinoline-1,2,3-triazoyl carboxamides as potential antinociceptive, anti-inflammatory and anticonvulsant agent

  2014cites this paper
• Benzoquinoline amines – Key intermediates for the synthesis of angular and linear dinaphthonaphthyridines

  2014cites this paper
• Indispensability of Quinoline Moiety in the Field of Medicinal Chemistry Research-A Review

  2014cites this paper
• Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products

  2013cites this paper
• Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives

  2013cites this paper
• Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis

  2013cites this paper
• Design, synthesis, and pharmacological properties of new heteroarylpyridine/heteroarylpyrimidine derivatives as CB(2) cannabinoid receptor partial agonists.

  2013cites this paper
• Recent development of CB2 selective and peripheral CB1/CB2 cannabinoid receptor ligands.

  2013cites this paper
• Quinoline: A versatile heterocyclic.

  2013cites this paper
• Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.

  2013cites this paper
• Medicinal chemistry of quinolines as emerging anti-inflammatory agents: an overview.

  2013cites this paper
• Regioselective construction of 1,3-diazaheterocycle fused [1,2-a][1,8]naphthyridine derivatives via cascade reaction of quinolines with heterocyclic ketene aminals: a joint experimental-computational approach.

  2013cites this paper
• Ethyl 1,4‐Dihydro‐4‐oxo‐1,8‐naphthyridine‐3‐carboxylates by a Tandem SNAr‐Addition‐Elimination Reaction

  2012cites this paper
• Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.

  2012cites this paper
• 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists.

  2012cites this paper
• Recent Developments in the Chemistry of Pyrazolo[4,3-c]quinolines

  2012cites this paper
• Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.

  2012cites this paper
• Virtual screening against obesity.

  2011cites this paper
• Composés de quinoléinone-pyrazolone modulateurs allostériques positifs du récepteur m1

  2010cites this paper
• Chinolinon-pyrazolon-m1-rezeptor-positive allosterische modulatoren

  2010cites this paper
• Facile Synthesis of Alkyl and Aryl Substituted Dibenzo[b,g][1,8]naphthyridin-5-ones

  2010cites this paper
• Use of the adamantane structure in medicinal chemistry.

  2010cites this paper
• The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies.

  2010cites this paper
• Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography.

  2010cites this paper
• CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists

  2010cites this paper
• The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry.

  2009cites this paper
• Endocannabinoid chemical biology: a tool for the development of novel therapies.

  2009cites this paper
• Latest advances in cannabinoid receptor agonists

  2009cites this paper
• Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.

  2009cites this paper
• Discovery of alpha-amidosulfones as potent and selective agonists of CB2: synthesis, SAR, and pharmacokinetic properties.

  2009cites this paper
• Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.

  2009cites this paper
• Simultaneous optimization of potency, selectivity and physicochemical properties for cannabinoid CB(2) ligands.

  2009cites this paper
• Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo.

  2008cites this paper
• Novel benzimidazole derivatives as selective CB2 agonists.

  2008cites this paper
• Advances in the development of novel analgesics

  2008cites this paper
• Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

  2008cites this paper
• Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2.

  2008cites this paper